Related Experiment Videos
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study
B G Durie1, J Crowley, C A Coltman
1University of Arizona Cancer Center.
Investigational New Drugs
|November 11, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Immunologic Aspects of the Hematologic Neoplasms.
Postgraduate medicine·2016
Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.
Investigational new drugs·2026
The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.
Investigational new drugs·2026
Chaetocin Induces Ferroptosis in Cisplatin-Resistant Ovarian Cancer Cells Through Neddylation-Mediated TFRC Upregulation.
Phytotherapy research : PTR·2026
Wogonin targets GATA1 to induce ferroptosis and potentiate cisplatin-mediated anti-tumor effects in esophageal squamous cell carcinoma.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Cartap hydrochloride induces dose-dependent oxidative stress and HSP70 overexpression in testicular tissue of Wistar rats: protective effect of α-tocopherol.
Reproductive toxicology (Elmsford, N.Y.)·2026
Effects of non-pharmacological interventions on chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis.
International journal of nursing studies·2026
Disulfiram reverses fluconazole-resistance mediated by Cdr1 in Candida albicans and interferes with biofilm formation.
Applied microbiology and biotechnology·2026